PharmaCyte Biotech Inc banner

PharmaCyte Biotech Inc
NASDAQ:PMCB

Watchlist Manager
PharmaCyte Biotech Inc Logo
PharmaCyte Biotech Inc
NASDAQ:PMCB
Watchlist
Price: 0.5402 USD -0.06% Market Closed
Market Cap: $5.8m

Intrinsic Value

The intrinsic value for PharmaCyte Biotech Inc (PMCB) under the Base Case is 3.8995 USD. Compared with the current market price of 0.5402 USD, the stock appears Undervalued by 86% .

Intrinsic value calculated using DCF
$3.8995

Do our valuations actually work? See backtest results .

PMCB Intrinsic Value
$3.8995
Undervaluation 86%
Intrinsic Value
Price $0.5402
Monitor PMCB
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $3.12
Get notified when the price drops into your buy zone
Intrinsic Value $3.9
Margin of Safety 20% $3.12
Current Price $0.54
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Ask AI Assistant
What other research platforms think about PMCB?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is PMCB valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for PharmaCyte Biotech Inc.

Explain Valuation
Alternatives to PMCB

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

PMCB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one PMCB stock?

The intrinsic value for PharmaCyte Biotech Inc (PMCB) under the Base Case is 3.8995 USD.

Is PMCB stock undervalued or overvalued?

Compared with the current market price of 0.5402 USD, the stock appears Undervalued by 86% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett